Hui Wu

127 Dongming Road
Zhengzhou, 450008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial.

Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial.

Journal: JAMA oncology

Published: January 29, 2026

Proton Bragg peak flash stereotactic radiosurgery for recurrent glioblastoma reirradiation.

Proton Bragg peak flash stereotactic radiosurgery for recurrent glioblastoma reirradiation.

Journal: Physics and imaging in radiation oncology

Published: September 13, 2025

Transcriptional regulation of nucleotide metabolism in medulloblastoma subtypes and prognostic implications analyzed by RNA-Seq.

Transcriptional regulation of nucleotide metabolism in medulloblastoma subtypes and prognostic implications analyzed by RNA-Seq.

Journal: Journal of cancer research and clinical oncology

Published: August 02, 2025

Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.

Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.

Journal: Nature cancer

Published: July 23, 2025

Assessing the potential and pitfalls of spot sequence optimization for OAR-specific dose rate control in proton PBS Bragg peak FLASH radiotherapy.

Assessing the potential and pitfalls of spot sequence optimization for OAR-specific dose rate control in proton PBS Bragg peak FLASH radiotherapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 26, 2025

Rewiring of de novo serine synthesis supports tumorigenesis under deficiency of TET2.

Rewiring of de novo serine synthesis supports tumorigenesis under deficiency of TET2.

Journal: British journal of cancer

Published: March 20, 2025

Advancing Proton FLASH Radiation Therapy: Innovations, Techniques, and Clinical Potentials.

Advancing Proton FLASH Radiation Therapy: Innovations, Techniques, and Clinical Potentials.

Journal: International journal of radiation oncology, biology, physics

Published: February 19, 2025

Metabolomic profiling of childhood medulloblastoma: contributions and relevance to diagnosis and molecular subtyping.

Metabolomic profiling of childhood medulloblastoma: contributions and relevance to diagnosis and molecular subtyping.

Journal: Journal of cancer research and clinical oncology

Published: August 15, 2024

Predictive Value of 18F-FDG PET/CT in LA-HNSCC Patients Undergoing Neoadjuvant Chemoimmunotherapy: A Prospective Study.

Predictive Value of 18F-FDG PET/CT in LA-HNSCC Patients Undergoing Neoadjuvant Chemoimmunotherapy: A Prospective Study.

Journal: Oral diseases

Published: July 11, 2024

The Potential and Challenges of Proton FLASH in Head and Neck Cancer Reirradiation.

The Potential and Challenges of Proton FLASH in Head and Neck Cancer Reirradiation.

Journal: Cancers

Published: July 11, 2024

Hexavalent chromium exposure induces lung injury via activation of NLRP3 and AIM2 inflammasomes in rats.

Hexavalent chromium exposure induces lung injury via activation of NLRP3 and AIM2 inflammasomes in rats.

Journal: Ecotoxicology and environmental safety

Published: July 04, 2024

A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy.

A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy.

Journal: International journal of immunopathology and pharmacology

Published: April 30, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026